IBDEI2AA ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38742,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 70-79% Body Surface
 ;;^UTILITY(U,$J,358.3,38742,1,4,0)
 ;;=4^L49.7
 ;;^UTILITY(U,$J,358.3,38742,2)
 ;;=^5009197
 ;;^UTILITY(U,$J,358.3,38743,0)
 ;;=L49.8^^151^1898^22
 ;;^UTILITY(U,$J,358.3,38743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38743,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 80-89% Body Surface
 ;;^UTILITY(U,$J,358.3,38743,1,4,0)
 ;;=4^L49.8
 ;;^UTILITY(U,$J,358.3,38743,2)
 ;;=^5009198
 ;;^UTILITY(U,$J,358.3,38744,0)
 ;;=L49.9^^151^1898^25
 ;;^UTILITY(U,$J,358.3,38744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38744,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ > 89% Body Surface
 ;;^UTILITY(U,$J,358.3,38744,1,4,0)
 ;;=4^L49.9
 ;;^UTILITY(U,$J,358.3,38744,2)
 ;;=^5009199
 ;;^UTILITY(U,$J,358.3,38745,0)
 ;;=Z65.5^^151^1898^26
 ;;^UTILITY(U,$J,358.3,38745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38745,1,3,0)
 ;;=3^Exposure to Disaster/War/Hostilities
 ;;^UTILITY(U,$J,358.3,38745,1,4,0)
 ;;=4^Z65.5
 ;;^UTILITY(U,$J,358.3,38745,2)
 ;;=^5063184
 ;;^UTILITY(U,$J,358.3,38746,0)
 ;;=Z77.22^^151^1898^27
 ;;^UTILITY(U,$J,358.3,38746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38746,1,3,0)
 ;;=3^Exposure to/Contact w/ Environmental Tobacco Smoke
 ;;^UTILITY(U,$J,358.3,38746,1,4,0)
 ;;=4^Z77.22
 ;;^UTILITY(U,$J,358.3,38746,2)
 ;;=^5063324
 ;;^UTILITY(U,$J,358.3,38747,0)
 ;;=L30.9^^151^1898^5
 ;;^UTILITY(U,$J,358.3,38747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38747,1,3,0)
 ;;=3^Eczema,Unspec
 ;;^UTILITY(U,$J,358.3,38747,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,38747,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,38748,0)
 ;;=L23.9^^151^1898^2
 ;;^UTILITY(U,$J,358.3,38748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38748,1,3,0)
 ;;=3^Eczema,Allergic Contact,Unspec
 ;;^UTILITY(U,$J,358.3,38748,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,38748,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,38749,0)
 ;;=L20.82^^151^1898^3
 ;;^UTILITY(U,$J,358.3,38749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38749,1,3,0)
 ;;=3^Eczema,Flexural
 ;;^UTILITY(U,$J,358.3,38749,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,38749,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,38750,0)
 ;;=L20.84^^151^1898^4
 ;;^UTILITY(U,$J,358.3,38750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38750,1,3,0)
 ;;=3^Eczema,Intrinsic
 ;;^UTILITY(U,$J,358.3,38750,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,38750,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,38751,0)
 ;;=L51.8^^151^1898^10
 ;;^UTILITY(U,$J,358.3,38751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38751,1,3,0)
 ;;=3^Erythema Multiforme,Other
 ;;^UTILITY(U,$J,358.3,38751,1,4,0)
 ;;=4^L51.8
 ;;^UTILITY(U,$J,358.3,38751,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,38752,0)
 ;;=R23.4^^151^1898^14
 ;;^UTILITY(U,$J,358.3,38752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38752,1,3,0)
 ;;=3^Eschar/Desquamination of Skin
 ;;^UTILITY(U,$J,358.3,38752,1,4,0)
 ;;=4^R23.4
 ;;^UTILITY(U,$J,358.3,38752,2)
 ;;=^5019296
 ;;^UTILITY(U,$J,358.3,38753,0)
 ;;=L49.9^^151^1898^23
 ;;^UTILITY(U,$J,358.3,38753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38753,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 90% or More Body Surface
 ;;^UTILITY(U,$J,358.3,38753,1,4,0)
 ;;=4^L49.9
 ;;^UTILITY(U,$J,358.3,38753,2)
 ;;=^5009199
 ;;^UTILITY(U,$J,358.3,38754,0)
 ;;=L74.9^^151^1898^1
 ;;^UTILITY(U,$J,358.3,38754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38754,1,3,0)
 ;;=3^Eccrine Sweat Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,38754,1,4,0)
 ;;=4^L74.9
 ;;^UTILITY(U,$J,358.3,38754,2)
 ;;=^5009296
